Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Ataxia telangiectasia: a review
2016
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 Standout
Macrophage metabolic reprogramming during chronic lung disease
2020
Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome
2018
Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
2010
Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage
2014
Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
2012
Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung
2013
Cystic fibrosis
2016 Standout
Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy
2017
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Clinical trials in cystic fibrosis
2007
Formyl-Peptide Receptors in Infection, Inflammation, and Cancer
2018
Lipid Mediators in the Resolution of Inflammation
2014
Neutrophil migration in infection and wound repair: going forward in reverse
2016
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Anti-inflammatory therapy in cystic fibrosis
2005
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
2018
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth
2015
In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells
2015
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Acute respiratory distress syndrome
2019 Standout
Resolution phase lipid mediators of inflammation: agonists of resolution
2013
A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation
2013
Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
2014
TFOS DEWS II Management and Therapy Report
2017 Standout
Paradigm Shift in the Pharmacological Management of Periodontal Diseases
2011
Gut microbiota, metabolites and host immunity
2016 Standout
Antiinflammatory Therapies for Cystic Fibrosis: Past, Present, and Future
2005
Neutrophils in cancer: neutral no more
2016 Standout
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
2007
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
2017 Standout
NAFLD: A multisystem disease
2015 Standout
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
2015
Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism
2019
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
2013
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Early Intravascular Events Are Associated with Development of Acute Respiratory Distress Syndrome. A Substudy of the LIPS-A Clinical Trial
2018
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases
2016
The future of biologics: Applications for food allergy
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Wound Healing: A Cellular Perspective
2018 Standout
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction
2011 Standout
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
The oral microbiota: dynamic communities and host interactions
2018 Standout
ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands
2013
Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS
2015
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of Olaf Eickmeier being referenced
118 Colistin intravenously is a safe and effective treatment of multidrug-resistant microorganisms in cystic fibrosis
2005
Altered mucosal immune response after acute lung injury in a murine model of Ataxia Telangiectasia
2014
Die Rolle neuer „pro-resolving” Lipidmediatoren bei entzündlichen Lungenerkrankungen
2010
Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis
2013
Immune Response, Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Lung Disease
2013
Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function
2010
Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis
2017
Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury
2012
The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung Disease
2011
Anti-inflammatory effects of montelukast in mild cystic fibrosis
2002
Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
2017
Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children
2010